A Study to Evaluate the Pharmacokinetics, Safety and Tolerability of ABBV-553 in Healthy Volunteers and in Subjects With Psoriasis and Efficacy of ABBV-553 in Subjects With Psoriasis
Clinical trial NCT03145948 · TERMINATED
Trial details
- NCT number
- NCT03145948
- Sponsor
- AbbVie
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-05-09
- Primary completion
- 2017-08-16
- Enrollment
- 12
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.